CapitalBio Becomes Roche NimbleGen Service Provider | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CapitalBio has been certified under the Roche NimbleGen Certified Service Provider program, Roche NimbleGen said today.

Under the program, CapitalBio has been certified to process customer samples for Roche NimbleGen's gene expression, comparative genomic hybridization and copy number variation, and DNA methylation services in CapitalBio's Beijing lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.